Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · SURAKSHA

SURAKSHA

HealthcareHealthcare Services₹1807 cr market cap
₹329.90 ▼ -5.21% today As of 19 Nov 2026
52-week low ₹227.9552-week high ₹356.45

-2.4% from the 52-week high · +52.7% above the low

Suraksha Diagnostic Ltd operates a network of diagnostic centers providing medical testing and healthcare services. The company offers advanced lab services, preventive healthcare solutions, and timely reports to patients. It aims to improve healthcare accessibility across urban and semi-urban areas while maintaining high standards of quality and safety.

The short version. SURAKSHA reported revenue of ₹99 crore for Sep 2026, up 25.3% from a year earlier. Net profit was ₹15 crore (up 66.7% year on year). Return on equity was 13.2% in Mar 2026. Promoter holding was 49.1% in Sep 2026, up 0.32 points over 8 quarters.

1 · The price

How has the stock traded?

SURAKSHA trades 2.4% below its 52-week high and 52.7% above its 52-week low.

Change over period: —

1M+16.8%
3M+12.8%
6M+14.1%
1Y+15.1%

2 · The business

Is it growing?

Sales, year on year+25.3%

Sep 2026 revenue of ₹99 cr.

Profit, year on year+66.7%

Sep 2026 net profit of ₹15 cr.

Net margin15.2%

3.8 pts higher than a year earlier.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue9988817879736560
Net profit1513689976
Net margin %15.214.87.79.711.412.911.410.1
EPS (₹)2.882.51.211.441.731.81.421.15

Annual

FY2026FY2025
Revenue310252
Net profit3232
Net margin %10.412.6
EPS (₹)6.186.11

3 · The quality

How well does it turn capital into profit?

Return on equity was 13.2% in Mar 2026; debt to equity is 0.01.

Profitability · 2 years

Returns and margins

Mar 2026Mar 2025
Return on equity %13.215.1
Return on capital %14.717.1
EBITDA margin %31.433.2
Net margin %10.312.4

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR——
Profit CAGR——
Debt to equity0.01
Interest cover4.6x
Current ratio1.05
P/E ratio43.5

4 · The owners

Who holds it, and are they adding?

Promoter holding49.1%

Up 0.32 pts over 8 quarters.

Foreign institutions13.97%

Down 1.42 pts over 8 quarters.

Domestic institutions21.56%

Up 1.12 pts over 8 quarters.

Mutual fund schemes10

+2 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter48.7848.7848.8848.9849.049.149.149.1+0.32
FII15.3914.4613.9513.7213.4613.4613.4713.97-1.42
DII20.4422.0522.3721.9822.5723.1423.2321.56+1.12
Public15.3914.714.815.3114.9814.3114.2115.37-0.02

Mutual fund holdings · Oct 2026

10 schemes hold this stock

8 the month before.

  • NIPPON INDIA PHARMA FUND1.36% of NAV
  • ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUND0.97% of NAV
  • JM Small Cap Fund0.83% of NAV
  • JM Value Fund0.82% of NAV
  • Kotak Small Cap Fund0.64% of NAV
  • Bandhan Innovation Fund0.44% of NAV
  • ADITYA BIRLA SUN LIFE ELSS TAX SAVER FUND0.39% of NAV
  • Bandhan Balanced Advantage Fund0.17% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for SURAKSHA are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about SURAKSHA

What is the SURAKSHA share price?

SURAKSHA (SURAKSHA) last closed at ₹329.90, down 5.21% on the day. Its 52-week range is ₹227.95 to ₹356.45.

What is the market cap of SURAKSHA?

SURAKSHA has a market capitalisation of about ₹1,807 crore. Its price-to-earnings ratio is 43.5.

How are SURAKSHA's latest results?

SURAKSHA reported revenue of ₹99 crore for Sep 2026, up 25.3% from a year earlier. Net profit was ₹15 crore (up 66.7% year on year). Return on equity was 13.2% in Mar 2026. Promoter holding was 49.1% in Sep 2026, up 0.32 points over 8 quarters.

Who owns SURAKSHA?

As of Sep 2026, shareholding was: Promoter 49.1%, FII 13.97%, DII 21.56%, Public 15.37%.

How many mutual funds hold SURAKSHA?

10 mutual fund schemes held SURAKSHA in October 2026. That compares with 8 the month before.

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.